VB

Vassiliki Boussiotis

DI Dana-Farber Cancer Institute: 9 patents #77 of 1,343Top 6%
BC Beth Israel Deaconess Medical Center: 2 patents #158 of 672Top 25%
Harvard University: 2 patents #1,071 of 3,600Top 30%
📍 Brookline, MA: #486 of 3,196 inventorsTop 20%
🗺 Massachusetts: #14,132 of 88,656 inventorsTop 20%
Overall (All Time): #534,021 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12258409 Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies Gordon J. Freeman, Xia Bu, Vikram Juneja, Arlene H. Sharpe, Nikolaos Patsoukis +2 more 2025-03-25
11492403 Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof Gordon J. Freeman, Xia Bu, Vikram Juneja, Arlene H. Sharpe, Nikolaos Patsoukis +2 more 2022-11-08
7700102 Nucleic acids encoding CD100 molecules Kathryn T. Hall, Gordon J. Freeman, Joachim L. Schultze, Lee M. Nadler, Laurence Boumsell +1 more 2010-04-20
7635757 B7-4 Antibodies and uses therefor Gordon J. Freeman, Tatyana Chernova, Nelly Malenkovich 2009-12-22
7038013 B7-4 polypeptides and uses therefor Gordon J. Freeman, Tatyana Chernova, Nelly Malenkovich 2006-05-02
6936704 Nucleic acids encoding costimulatory molecule B7-4 Gordon J. Freeman, Tatyana Chernova, Nelly Malenkovich 2005-08-30
6576236 Methods for stimulating T cell responses by manipulating a common cytokine receptor &ggr; chain Lee M. Nadler 2003-06-10
6576754 CD100 antigen and uses therefor Kathryn T. Hall, Gordon J. Freeman, Joachim L. Schultze, Lee M. Nadler 2003-06-10
6451305 Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligand Gordon J. Freeman, Lee M. Nadler 2002-09-17